Ayala Pharmaceuticals



Ayala Pharmaceuticals is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations.

Gary Gordon
Chief Medical Officer
Yossi Maimon
Chief Financial Officer
Dana Gelbaum
Chief Business Officer
Gili Hart
Chief Development Officer
David Caron
Carmit Nadri-Shay
VP, Regulatory Affairs
Irit Klipper-Avni
VP, Human Resources
Joel Kaye
VP, Research & Nonclinical Development

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.